Serum antioxidant vitamins and risk of cataract
- PMID: 1486302
- PMCID: PMC1883919
- DOI: 10.1136/bmj.305.6866.1392
Serum antioxidant vitamins and risk of cataract
Abstract
Objective: To investigate serum concentrations of alpha tocopherol, beta carotene, retinol, and selenium for their prediction of end stage cataract.
Design: A case-control study, nested within a cohort study, based on the linkage of records of subjects aged 40-83 from a health survey with those from the national Finnish hospital discharge register.
Subjects: 47 patients admitted to ophthalmological wards for senile cataract over 15 years and two controls per patient individually matched for sex, age, and municipality.
Main outcome measure: Concentration of serum micronutrients, development of cataract according to whether operation was performed.
Results: Low serum concentrations of antioxidant vitamins predicted the development of senile cataract, the odds ratio between the lowest third and the two higher thirds of the distribution of serum concentrations of alpha tocopherol and beta carotene being 1.9 (95% confidence interval 0.9 to 4.1) and 1.7 (0.8 to 3.8), respectively. Patients with both alpha tocopherol and beta carotene concentrations in the lowest third had an odds ratio of 2.6 (1.0 to 6.8) of cataract compared with subjects in the top two thirds. The associations were strengthened by adjustment for potential confounding factors such as occupation, smoking, blood pressure, serum cholesterol concentration, body mass index, and diabetes. No association was found between the serum concentrations of selenium, retinol, and retinol binding protein and the risk of cataract.
Conclusions: Low serum concentrations of the antioxidant vitamins alpha tocopherol and beta carotene are risk factors for end stage senile cataract. Controlled trials of the role of antioxidant vitamins in cataract prevention are therefore warranted.
Similar articles
-
Serum beta-carotene and antioxidant micronutrients in children with cancer. The 'Cancer in Children and Antioxidant Micronutrients' French Study Group.Int J Epidemiol. 1993 Oct;22(5):761-71. doi: 10.1093/ije/22.5.761. Int J Epidemiol. 1993. PMID: 8282453
-
Prospective study of serum micronutrients and ovarian cancer.J Natl Cancer Inst. 1996 Jan 3;88(1):32-7. doi: 10.1093/jnci/88.1.32. J Natl Cancer Inst. 1996. PMID: 8847723
-
Serum micronutrients and risk of cancers of low incidence in Finland.Am J Epidemiol. 1991 Aug 15;134(4):356-61. doi: 10.1093/oxfordjournals.aje.a116097. Am J Epidemiol. 1991. PMID: 1877596
-
Serum levels of retinol, beta-carotene, and alpha-tocopherol in older adults.Am J Epidemiol. 1988 Jan;127(1):114-23. doi: 10.1093/oxfordjournals.aje.a114771. Am J Epidemiol. 1988. PMID: 3276153 Review.
-
Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer.Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):451-7. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12010859 Review.
Cited by
-
Hydrogen Sulfide: Novel Endogenous and Exogenous Modulator of Oxidative Stress in Retinal Degeneration Diseases.Molecules. 2021 Apr 21;26(9):2411. doi: 10.3390/molecules26092411. Molecules. 2021. PMID: 33919146 Free PMC article. Review.
-
Prospective study showing that dietary vitamin C reduced the risk of age-related cataracts in a middle-aged Japanese population.Eur J Nutr. 2007 Mar;46(2):118-24. doi: 10.1007/s00394-006-0641-8. Eur J Nutr. 2007. PMID: 17265171
-
Should antioxidant vitamins be routinely recommended for older people?Drugs Aging. 1998 Mar;12(3):169-75. doi: 10.2165/00002512-199812030-00001. Drugs Aging. 1998. PMID: 9534018 Review.
-
Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.JAMA Ophthalmol. 2015 Jan;133(1):17-24. doi: 10.1001/jamaophthalmol.2014.3478. JAMA Ophthalmol. 2015. PMID: 25232809 Free PMC article. Clinical Trial.
-
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.Arch Ophthalmol. 2001 Oct;119(10):1439-52. doi: 10.1001/archopht.119.10.1439. Arch Ophthalmol. 2001. PMID: 11594943 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical